the aid library

Internal Medicine Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

Preparação e Resposta à Introdução do Vírus Chikungunya no Brasil

Ministeria de Saude, Brasil (2014)

Baseado no livro Preparación y respuesta ante la eventual introducción del virus chikungunya en las américas

Directrices unificadas sobre prevención, diagnóstico, tratamiento y atención de la infección por el VIH para grupos de población clave (Julio 2017)

Pan American Health Organization (PAHO) (2019) C_WHO

En estas nuevas directrices unificadas sobre prevención, diagnóstico, tratamiento y atención de la infección por el VIH para grupos de población clave, la Organización Mundial de la Salud (OMS) reúne toda la orientación existente que es pertinente para cinco grupos clave de la población — ... more

Promoting access to medical technologies and innovation, second edition, 30 August 2021

World Health Organization WHO and World Intellectual Property Organization WTO, WHO, WIPO (2021) CC

The second edition of the joint WHO, WIPO and WTO publication “Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade” (the Trilateral Study),* published in 2020, included a special insert mappi ... more

WHO Emergency Response Framework - Internal WHO procedures - Second Edition

World Health Organization WHO (2024) C_WHO

The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a ... more

La política de salvaguarda infantil de la CBM

Christoffel-Blindenmission (CBM) (2014)

La política de salvaguarda infantil de la CBM se basa en la Convención sobre los Derechos del Niño de la ONU de 1989 (y en sus protocolos facultativos) y en la legislación nacional de protección infantil de Alemania, así como en la de los países participantes en el programa de la CBM y la nor ... more

Scoping review of interventions to maintain essential services for maternal, newborn, child and adolescent health and older people during disruptive events

World Health Organization WHO (2021) C_WHO

To support countries in adapting their response to different COVID-19 scenarios, the World Health Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissioned this scoping review of published and grey literature. The objective was to identify interventions ... more

Kenya: Transforming Health: Accelerating Attainment of Universal Health Coverage

Kenya Health Sector Strategic and Investment Plan (KNSSP) (2014) C1

Polio vaccines: WHO position paper – June 2022
recommended

World Health Organization WHO (2022) C_WHO

This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.

Clinical Updates in Reproductive Health

Alice Mark IPAS (2016) C1

The publication is designed to provide Ipas staff, trainers, partners and other health-care providers with access to up-to-date, evidence-based recommendations. In general, the recommendations are the same as those in the World Health Organization’s 2012 Safe Abortion: Technical and Policy Guidanc ... more

COVID-19: Immediate Socio-Economic Response Plan - United Nations in India

UNSDG (2020) CC

In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare, ... more

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector ... al population-based interventions to reduce CVD risk factors in the entire population. Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs. Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management. Conclusion: The large burden of CVD in LMICs and the fact that persons with high CVD can be identified and managed along cost-effective interventions mean that health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level. more

Developmental Disabilities

Institute of Medicine (US); Committee on Nervous System Disorders in Developing Countries; National Academy of Sciences (2001) C2

Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries. Washington (DC): National Academies Press (US); 2001.

Formulary of Narcotic Drugs and Psychotropic Substances for Ethiopia

Drug Administration and Control Authority (DACA) of Ethiopia (2004) C1

Positioning zoonotic disease research in forced migration: A systematic literature review of theoretical frameworks and approaches

Tasker, A.; Braam, D. PLOS ONE (2021) C1

The emergence and transmission of zoonotic diseases are driven by complex interactions between health, environmental, and socio-political systems. Human movement is considered a significant and increasing factor in these processes, yet forced migration remains an understudied area of zoonotic res ... more

Identificación y tratamiento del síndrome de Guillain-Barré en el contexto del brote de virus de Zika

Organización Mundial de la Salud (2016) C_WHO

El objetivo del presente documento consiste en ofrecer orientaciones provisionales sobre la definición de los casos de SGB y las estrategias para tratar el síndrome en el contexto del brote de virus de Zika y de su posible relación con el SGB. Asimismo, pretende servir como base para la elab ... more

WHO best practices for injections and related procedures toolkit

World Health Organization; SIGN (2010) C_WHO

The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.

Health systems context(s) for integrating mental health into primary health care in six Emerald countries: a situation analysis

Mugisha J.; Abdulmalik, J.; Hanlon C; et al. International Journal of Mental Health Systems; BioMed Central (2017) C1

Mugisha et al. Int J Ment Health Syst (2017) 11:7 DOI 10.1186/s13033-016-0114-2